feed,title,long_url,short_url
Benzinga,Novartis' Scemblix Snags European Approval For Chronic Myeloid Leukemia,https://benzinga.com/general/biotech/22/08/28664596/novartis-scemblix-snags-european-approval-for-chronic-myeloid-leukemia,https://bit.ly/3QZKh27
